These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1668800)

  • 41. Evidence against insulin synthesis BY IM-9 lymphocytes.
    Bauman WA; Hatcher VB; Levitt MA; Yalow RS
    Diabetes; 1982 Feb; 31(2):182-4. PubMed ID: 6295854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification of radiolabeled oligonucleotides by chromatography on a sep-pak c18 column.
    Sambrook J; Russell DW
    CSH Protoc; 2006 Jun; 2006(1):. PubMed ID: 22485476
    [No Abstract]   [Full Text] [Related]  

  • 43. Simple and rapid purification of radiolabeled [14C]cyclophosphamide by Sep Pak C18 cartridges.
    Gattavecchia E; Tonelli D
    Int J Appl Radiat Isot; 1983 Nov; 34(11):1553-4. PubMed ID: 6642713
    [No Abstract]   [Full Text] [Related]  

  • 44. Correction to: Prediction of future weight change with the dopamine transporter : Kyoungjune pak.
    Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
    Brain Imaging Behav; 2023 Jun; 17(3):372. PubMed ID: 37095417
    [No Abstract]   [Full Text] [Related]  

  • 45. Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.
    Renes JS; van Doorn J; Hokken-Koelega ACS
    Horm Res Paediatr; 2019; 92(1):15-27. PubMed ID: 31509834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II.
    Daughaday WH; Trivedi B; Baxter RC
    Endocrine; 1995 Jun; 3(6):425-8. PubMed ID: 21153246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity.
    Janssen JA; van der Lely AJ; Lamberts SW
    J Endocrinol Invest; 2003 Jun; 26(6):588-94. PubMed ID: 12952376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary IGF-I measurement and its clinical application.
    Hizuka N; Takano K; Asakawa K; Sukegawa I; Horikawa R; Yoshizawa Y; Saito S; Shizume K
    Acta Paediatr Scand Suppl; 1988; 347():127-33. PubMed ID: 3254027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demonstration of insulin-like growth factor I in human urine.
    Hizuka N; Takano K; Tanaka I; Asakawa K; Miyakawa M; Horikawa R; Shizume K
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1309-12. PubMed ID: 3571431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
    Thissen JP; Ketelslegers JM; Maiter D
    Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of free form of insulin-like growth factor I in human plasma.
    Hizuka N; Takano K; Asakawa K; Sukegawa I; Fukuda I; Demura H; Iwashita M; Adachi T; Shizume K
    Growth Regul; 1991 Jun; 1(2):51-5. PubMed ID: 1668800
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.